The Federal Trade Commission has closed its investigation of whether the Texas Medical Board violated federal antitrust law by adopting rules restricting the practice of telemedicine and telehealth in Texas. The Commission voted to close the investigation after Texas enacted a law that overrides the board’s restrictive rules. In a statement explaining its reasoning, the […]
Tag Archives: Health Care Bureau of Competition Competition
Puerto Rico Ophthalmologist Group Settles FTC Charges that Members Agreed to an Illegal Boycott of Health Plan
OFTACOOP, a Puerto Rico ophthalmologist cooperative, has agreed to settle Federal Trade Commission charges that its actions harmed competition. The complaint charges that OFTACOOP – also known as Cooperativa de Médico Oftalmólogos de Puerto Rico – unlawfully orchestrated an agreement among competing ophthalmologists to refuse to deal with a health plan, MCS Advantage, Inc., and […]
FTC Amicus Brief Urges Appeals Court to Reverse District Court’s Dismissal of Amphastar Pharmaceuticals, Inc. v. Momenta Pharmaceuticals, Inc.
The Federal Trade Commission filed an amicus brief with the U.S. Court of Appeals for the First Circuit urging the court to reverse the district court’s dismissal of the complaint in Amphastar Pharmaceuticals, Inc. v. Momenta Pharmaceuticals, Inc. The amicus brief explains that the district court’s basis for dismissing the complaint, the Noerr–Pennington doctrine, was […]
Amicus Brief Filed by FTC and DOJ Urges Appeals Court to Dismiss Appeal by Texas Medical Board in Antitrust Lawsuit
On September 9, 2016, the Federal Trade Commission and Department of Justice filed a joint amicus brief urging the U.S. Court of Appeals for the Fifth Circuit to dismiss an appeal by the Texas Medical Board of a district court decision holding that Board regulations restricting telehealth services may be challenged under federal antitrust laws. […]
FTC Testifies on Antitrust Enforcement in the Health Care Industry
The Federal Trade Commission testified today before Congress on how it protects and promotes competition in the health care industry to help make sure U.S. consumers get high-quality care at competitive prices. Continuing effective antitrust enforcement is a critical part of any plan to improve the health care system, according to the testimony. The testimony […]